# DESCRIPTION

## FIELD

- introduce alphavirus replicons for RNA therapeutics

## BACKGROUND

- motivate nucleic acid therapeutics
- describe limitations of synthetic RNA

## SUMMARY

- motivate replicon-based RNA therapeutics
- describe in vitro evolution method
- describe engineering mutated replicon
- describe administering replicon to subject
- describe enhancing replicon persistence
- describe subgenomic expression of therapeutic agent
- describe in vitro evolution of alphavirus replicons
- describe engineering synthetic replicon construct
- describe transfecting replicon RNA into cells
- describe sorting and culturing transfected cells
- describe identifying mutations
- describe testing mutated replicon RNA

## DETAILED DESCRIPTION

- introduce alphavirus replicons as gene therapy and vaccination platforms
- describe virus structure and function
- define structural and non-structural proteins
- describe alphavirus genus and examples of alphaviruses
- introduce VEE alphavirus replicon
- describe VEE virus structure and function
- define non-structural proteins and their roles
- introduce in vitro evolution of replicons
- describe method for in vitro evolution of synthetic replicon RNA
- define transfection and host cell
- describe methods of transfection
- introduce cell sorting and separation criteria
- describe cell culture methods
- introduce synthetic replicon construct with non-structural proteins
- describe replacement of structural proteins with genes of experimental or therapeutic interest
- introduce cytokines, chemokines, and growth factors as examples of genes of interest
- describe subgenomic promoter and untranslated regions
- introduce detectable molecule in subgenomic region
- describe fluorescent proteins as detectable molecules
- introduce in vitro transcription of replicon RNA
- describe T7 RNA polymerase
- introduce IVE method
- describe cell types used
- explain interferon response
- detail cell culture and transfection
- describe FACS sorting
- outline re-culturing and re-sorting
- identify mutations
- extract and sequence RNA
- clone and sequence cDNA
- describe vector and cloning
- outline method of testing RNA replicon
- transfect and track expression
- describe RAW-Lucia ISG cells
- track fluorescent protein expression
- compare expression to wild-type
- describe method of expressing mutated RNA replicons in vivo
- prepare and administer lipid nanoparticles
- describe method of comparing persistence and strength of mutations
- outline administration routes and pharmaceutical compositions

### EXAMPLES

- introduce cell lines and animals
- describe constructs, in vitro transcription, and neon transfection
- outline in vitro evolution screen
- assemble mutant replicons
- describe antibodies, flow cytometry, sorting, and analysis
- outline RNA extraction and quantitative PCR analysis
- formulate lipid nanoparticles for in vivo delivery

### EXAMPLE 1

- introduce in vitro evolution strategy
- describe transfection and passage of replicons
- identify mutations in replicon RNA

### EXAMPLE 2

- analyze impact of mutations on gene expression

### EXAMPLE 3

- evaluate impact of mutations on replicon RNA persistence
- analyze subgenomic transcription
- measure interferon responses
- discuss mechanisms underlying changes in IFN responses
- summarize results of IVE screen

### EXAMPLE 4

- evaluate mutant replicons in vivo

### EXAMPLE 5

- analyze enhanced anti-tumor immunity stimulated by mutant replicons
- discuss therapeutic potential of mutant replicons

## Other Embodiments

- describe alternative features and modifications

## Equivalents and Scope

- describe equivalents and scope of invention
- describe variations and modifications
- describe parameters and configurations
- describe individual features and combinations
- describe definitions and references

